Menu ×


Diabetes Disposable Insulin Pen Market Segmentation By Type of Diabetes (Type I Diabetes and Type II Diabetes); By Capacity (300 Units, 600 Units and 900 Units); By Needle Type (Standard Insulin Pen Needles and Safety Insulin Pen Needles); By Distribution Channel (Hospital Pharmacies, Retail Pharmacies and Online); By Application (Hospitals, Clinics and Home Care) – Global Demand Analysis & Opportunity Outlook 2028

  • Text Size:

Inflation And Looming Recession to Haunt Businesses:

In 2022 & 2023, market players expected to sail in rough waters; might incur losses due to huge gap in currency translation followed by contracting revenues, shrinking profit margins & cost pressure on logistics and supply chain. Further, U.S. economy is expected to grow merely by 3% in 2022.

Request Insights

Purchasing power in the couPurchasing power in the country is expected to fell nearly by 2.5%. On the other hand, European countries to see the worst coming in the form of energy crisis especially in upcoming winters!! Right after COVID-19, inflation has started gripping the economies across the globe. Higher than anticipated inflation, especially in western world had raised concerns for national banks and financial institutions to control the economic loss and safeguard the interest of the businesses. Increased interest rates, strong USD inflated oil prices, looming prices for gas and energy resources due to Ukraine-Russia conflict, China economic slowdown (~4% in 2022) disrupting the production and global supply chain and other factors would impact each industry negatively.                                                         Request Insights

Read More


  • On October 1, 2018, Novo Nordisk announced its plans to produce connected insulin pens, NovoPen® 6 and NovoPen Echo® Plus, that would be durable and provide wider digital health solutions. 

Introduction to Diabetes Disposable Insulin Pen

Insulin pens are increasingly becoming common in place of traditional insulin injections as they provide the patients with an easy and convenient system for insulin delivery. These pens need to be refrigerated constantly. They can be either disposable or reusable. Disposable insulin pens contain cartridges that are pre-filled with insulin and hence do not require insulin vials. They are then thrown away after single-use along with the needle. The amount of insulin units present in every disposable insulin pen varies along with the capacity. Insulin pens are portable, less time consuming and allow users to administer an accurate dosage of the hormone every time.

Market Size and Forecast

According to International Diabetes Federation, around 463 million adults between the ages 20 and 79 were living with diabetes in 2019. This number is further estimated to increase to 700 million people by 2045.

The market for disposable insulin pens for diabetes is estimated to witness substantial growth in the coming years. This can be attributed to the numerous advantages offered by these pens over insulin syringes. The diabetes disposable insulin pen market is anticipated to record a significantly high CAGR over the forecast period, i.e., 2020-2028. The market is segmented by type of diabetes, by capacity, by needle type, by distribution channel, by application and by region, out of which, the type of diabetes segment is bifurcated into type I diabetes and type II diabetes. As per the data by International Diabetes Federation, it has been observed that the percentage of people with type II diabetes is growing at a high rate in most countries. Insulin is majorly used in cases of type II diabetes, which accounts for the estimated increase in growth of this segment. The distribution channel segment is further segmented into hospital pharmacies, retail pharmacies and online. Retail pharmacies hold the largest share in the market on account of easy availability of disposable insulin pens at the pharmacies and presence of retail pharmacies in almost every area. However, the online segment is anticipated to grow at the highest rate during the forecast period as a result of it being a highly convenient method of purchasing the device. On the basis of application, the market is segmented into hospitals, clinics and home care, out of which, the home care segment is anticipated to observe the highest growth rate as a result of increased usage of insulin pens for self-administration by patients at home. CLICK TO DOWNLOAD SAMPLE REPORT

Diabetes Disposable Insulin Pen Market

Growth Drivers

Growing Diabetes Population To Drive The Growth Of Overall Market

Diabetes is increasingly becoming common across major parts of the world. The growing incidence of type I and type II diabetes, especially among the geriatric population, raises the demand for insulin therapy. Moreover, data presented by the World Bank suggests that diabetes was prevalent in about 10.8% of the total population of the United States and 8.8% of the total world’s population in 2019. On account of these factors, the market for disposable insulin pens is anticipated to grow at a notable rate in the coming years.

User-Friendly Design Of Insulin Pens To Promote Market Growth

Disposable insulin pens are created in such a way that they can be used by people who are newly diagnosed with diabetes as well as old-aged people. Use of insulin pens ensures supply of accurate insulin dosage and makes the process of delivery easier. Further, the increasing demand for self-administration of insulin, ease of use and lower risk of infection through disposable insulin pens are some factors anticipated to lead to the growth of this market.


High Cost Of Disposable Insulin Pens To Restrict The Market Growth

Disposable insulin pens might be more expensive than insulin bottles and syringes. This is estimated to restrict a large section of the population from purchasing these pens, which becomes a restraint to the market growth.

Market Segmentation

Our in-depth analysis of the diabetes disposable insulin pen market includes the following segments:

By Type of Diabetes

  • Type I Diabetes
  • Type II Diabetes

By Capacity

  • 300 Units
  • 600 Units
  • 900 Units

By Needle Type

  • Standard Insulin Pen Needles
  • Safety Insulin Pen Needles

By Distribution Channel

  • Hospital Pharmacies
  • Retail Pharmacies
  • Online

By Application

  • Hospitals
  • Clinics
  • Home Care

By Region

On the basis of regional analysis, the diabetes disposable insulin pen market is segmented into five major regions including North America, Europe, Asia Pacific, Latin America and Middle East & Africa region. The largest market share for disposable insulin pens is estimated to be held by the North America region on the back of growing innovations in the healthcare industry in the region, especially in the United States, which results in the development of improved medical devices such as these disposable insulin pens for diabetes. The market in Asia Pacific region is predicted to grow at the highest rate over the forecast period as a result of rising prevalence of diabetes in the region. Countries such as India, China and Japan consist of a large diabetes patient population, which raises the demand for effective and easy-to-use methods for managing diabetes. As per the World Bank, diabetes affected 10.4% of the total population of India, 9.2% of the population of China and 5.6% of the total population of Japan in 2019.On the other hand, European market for disposable insulin pens is anticipated to observe significant growth as well. This can be attributed to the rising consumer demand, technological advancements and favorable government initiatives supporting the market, mainly in Germany, United Kingdom, France, Spain and Italy.

Diabetes Disposable Insulin Pen Market Segmentation by Region

The diabetes disposable insulin pen market is further classified on the basis of region as follows:

  • North America (U.S. & Canada) Market size, Y-O-Y growth & Opportunity Analysis
  • Latin America (Brazil, Mexico, Argentina, Rest of Latin America) Market size, Y-O-Y growth & Opportunity Analysis
  • Europe (U.K., Germany, France, Italy, Spain, Hungary, Belgium, Netherlands & Luxembourg, NORDIC,  Poland, Turkey, Russia, Rest of Europe) Market size, Y-O-Y growth & Opportunity Analysis
  • Asia-Pacific (China, India, Japan, South Korea, Indonesia, Malaysia, Australia, New Zealand, Rest of Asia-Pacific) Market size, Y-O-Y growth & Opportunity Analysis.
  • Middle East and Africa (Israel, GCC (Saudi Arabia, UAE, Bahrain, Kuwait, Qatar, Oman), North Africa, South Africa, Rest of Middle East and Africa) Market size, Y-O-Y growth & Opportunity Analysis

Top Featured Companies Dominating the Market

  • Novo Nordisk
    • Company Overview
    • Business Strategy
    • Key Product Offerings
    • Financial Performance
    • Key Performance Indicators
    • Risk Analysis
    • Recent Development
    • Regional Presence
    • SWOT Analysis 
  • Eli Lilly
  • Sanofi SA

Related Reports

Disclaimer | Privacy Policy | Terms & Conditions | LOB

Copyright © 2022 Research Nester. All Rights Reserved